Výsledky vyhľadávania

Nájdených záznamov: 3  
Váš dotaz: Autor-kód záznamu + druh.dok = "^sllk_un_auth d017152 250m^"
  1. SYSd016736
    LBL
      
    00000cx--j2200000---45--
    005
      
    20240119201309.7
    100
      
    $a 19920429asloy0103----ba0
    152
      
    $b mesh
    250
      
    $a syndróm antifosfolipidový $x BL $x CF $x CI $x CL $x CN $x CO $x DG $x DH $x DI $x DT $x EC $x EH $x EM $x EN $x EP $x ET $x GE $x HI $x IM $x ME $x MI $x MO $x NU $x PA $x PC $x PP $x PS $x PX $x RH $x RT $x SU $x TH $x UR $x VE $x VI $8 slo
    300
    1-
    $a 92; PHOSPHOLIPID ANTIBODY SYNDROME was see ANTIPHOSPHOLIPID SYNDROME 1992 $8 eng
    300
    1-
    $a Phospholipids/immunology (1977-1991) $8 eng
    330
    1-
    $a The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR). $8 eng
    450
      
    $a Hughesov syndróm $5 e $8 slo
    550
      
    $3 sllk_un_auth*d002308 $Y Cardiolipins $5 B $a kardiolipíny
    550
      
    $3 sllk_un_auth*d008180 $Y Lupus Erythematosus, Systemic $5 B $a lupus erythematosus, systémový
    550
      
    $3 sllk_un_auth*d010743 $Y Phospholipids $5 B $a fosfolipidy
    550
      
    $3 sllk_un_auth*d016682 $Y Lupus Coagulation Inhibitor $5 B $a lupus antikoagulans
    550
      
    $3 sllk_un_auth*d017152 $Y Antibodies, Antiphospholipid $5 B $a protilátky antifosfolipidové
    686
      
    $a C20.111.197
    750
      
    $a Antiphospholipid Syndrome $8 eng
    801
    -0
    $a US $b DNLM $c 19920429
    801
    -2
    $a SK $b BA006 $c 20070706
    801
    -2
    $a SK $b BA006 $c 20160211
    980
      
    $x M
  2. SYSd045163
    LBL
      
    00000nx--j22000003--45--
    005
      
    20240119201434.6
    100
      
    $a 20030709csloy0103----ba0
    152
      
    $b mesh
    250
      
    $a protilátky fosfo-špecifické $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PO $x RE $x TO $x TU $x UL $x UR $8 slo
    300
    1-
    $a 2004 $8 eng
    330
    1-
    $a Antibodies directed against immunogen-coupled phosphorylated PEPTIDES corresponding to amino acids surrounding the PHOSPHORYLATION site. They are used to study proteins involved in SIGNAL TRANSDUCTION pathways. (From Methods Mol Biol 2000; 99:177-89) $8 eng
    450
      
    $a Antibodies, Antiphosphopeptide-Specific $5 e $8 eng
    450
      
    $a Antibodies, Phosphopeptide-Specific $5 e $8 eng
    450
      
    $a Phospho-Specific Antibodies $5 e $8 eng
    450
      
    $a Phosphopeptide-Specific Antibodies $5 e $8 eng
    450
      
    $a Phosphorylation State-Specific Antibodies $5 e $8 eng
    450
      
    $a protilátky špecifické pre antifosfopeptid $5 e $8 slo
    450
      
    $a protilátky antifosfopeptid-špecifické $5 e $8 slo
    450
      
    $a protilátky špecifické pre fosfopeptid $5 e $8 slo
    450
      
    $a protilátky fosfopeptid-špecifické $5 e $8 slo
    450
      
    $a protilátky špecifické pre fosforylovaný stav $5 e $8 slo
    450
      
    $a protilátky špecifické pre fosforylované štádium $5 e $8 slo
    550
      
    $3 sllk_un_auth*d017152 $Y Antibodies, Antiphospholipid $5 B $a protilátky antifosfolipidové
    550
      
    $3 sllk_un_auth*d007155 $Y Immunologic Factors $5 P $a faktory imunologické
    550
      
    $3 sllk_un_auth*d017152 $Y Antibodies, Antiphospholipid $5 F $a protilátky antifosfolipidové
    686
      
    $a D12.776.124.486.485.114.248
    686
      
    $a D12.776.124.790.651.114.248
    686
      
    $a D12.776.377.715.548.114.248
    750
      
    $a Antibodies, Phospho-Specific $8 eng
    801
    -0
    $a US $b DNLM $c 20030709
    801
    -2
    $a SK $b BA006 $c 20040609
    820
      
    $a do not confuse with ANTIBODIES, ANTIPHOSPHOLIPID $8 eng
    980
      
    $x M
  3. SYSd010743
    LBL
      
    00000cx--j2200000---45--
    005
      
    20240119201129.2
    100
      
    $a 19990101asloy0103----ba0
    152
      
    $b mesh
    250
      
    $a fosfolipidy $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo
    300
    1-
    $a /metabolism was PHOSPHOLIPID METABOLISM 1965 $8 eng
    330
    1-
    $a Lipids containing one or more phosphate groups, particularly those derived from either glycerol (phosphoglycerides see GLYCEROPHOSPHOLIPIDS) or sphingosine (SPHINGOLIPIDS). They are polar lipids that are of great importance for the structure and function of cell membranes and are the most abundant of membrane lipids, although not stored in large amounts in the system. $8 eng
    450
      
    $a Phosphatides $5 e $8 eng
    450
      
    $a Phospholipid $5 e $8 eng
    450
      
    $a fosfolipid $5 e $8 slo
    450
      
    $a fosfatidy $5 e $8 slo
    550
      
    $3 sllk_un_auth*d017152 $Y Antibodies, Antiphospholipid $5 F $a protilátky antifosfolipidové
    550
      
    $3 sllk_un_auth*d016736 $Y Antiphospholipid Syndrome $5 F $a syndróm antifosfolipidový
    686
      
    $a D10.570.755
    750
      
    $a Phospholipids $8 eng
    801
    -0
    $a US $b DNLM $c 19990101
    801
    -2
    $a SK $b BA006 $c 20070706
    801
    -2
    $a SK $b BA006 $c 20210921
    980
      
    $x M


  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.